Pharmaxis to Be Renamed Syntara and Will Primarily Focus on Clinical Development
Pharmaxis to Be Renamed Syntara and Will Primarily Focus on Clinical Development
Pharmaxis 将更名为 Syntara，将主要专注于临床开发
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间